November 30, 2009
By John Rappoport
We are at a defining and crucial moment in our history. A machine is in motion that will alter our future. If after you read this article, you agree with its main points, or at least feel they need to be heard, send it on to others. Find ways to make your voice count.
It is one thing to read and understand the details of the Obama Health Plan. It is another thing to grasp the kind of power this bill will create, and what that power, in the future, will mean and do.
I realize that many people reading this essay have no interest in alternative medicine. However, that field represents freedom of choice for millions of Americans, and if you want to deny that choice—because you have a mistaken notion about, and a misplaced faith in, how medical science actually operates—the medical facts I describe and cite below should bring about a new appreciation of what freedom looks like, and how important the job of protecting it is.
This might be the most important medical article I’ve ever written, and in 20 years as a reporter, I’ve written many.
As I begin this essay on Thanksgiving morning, I recall that, 15 years ago, I was preparing to challenge Henry Waxman for his seat in the US House, in the 29th District, Los Angeles. At that time, the issue was Health Freedom, the right of every American to choose how to maintain and improve his/her health. And here I am again, with the same issue—only this time, there is a gargantuan White House program in place to destroy that freedom from the top down.
And various alternative-health advocates, having lost their minds, are supporting it. Among them are people who actually believe the small affirmative nods from politicians, in the direction of alternative medicine, are signaling an enlightened age under the Obama Star.
Duped again. One more time.
I have never imagined Democrats or Republicans represented the American people. This time, it is the political Left, with their naïve belief in “science” and “humanitarian work” who are leading the country over a cliff.
In the same way climate-change researchers have recently been exposed as charlatans, manipulators, and elitists, the medical establishment has been laid open and flayed—only the revelations came nine years ago. And of course, the major media refused to chase down that story and shine a light on the criminals.
On July 26, 2000, the Journal of the American Medical Association published a landmark paper by Barbara Starfield (Johns Hopkins School of Public Health), “Is US health really the best in the world?” In it, Starfield revealed what many people inside the medical establishment already knew: every year, like clockwork, the medical system was killing huge numbers of people. This wasn’t a dream. It was too real. By all rights (but who cares about rights?) the game was up. The liars and the PR flacks and the public health agencies were going down. The drug companies were going to take a lethal blow. Hospitals all over America were going to have to confess their many sins. Of course, that never happened.
November 30, 2009
The following information may be the most important we have ever published. One of our Intel sources, highly placed in banking circles, tells us that on 1/1/10 all banks that have received TARP funds have been informed by the Federal Reserve that they must further restrict any commercial lending. Loans have to be 75% collateralized, 50% of which has to be in cash, which is a compensating balance.
The Fed has to do one of two things: They either have to pull $1.5 trillion out of the system by June, which would collapse the economy, or face hyperinflation. This is why the Fed has instructed banks to inform them when and how much of the TARP funds they can return. At best they can expect $300 to $400 billion plus the $200 billion the Fed already has in hand.
We believe the Fed will opt for letting the system run into hyperinflation. All signs tell us they cannot risk allowing the undertow of deflation to take over the economy. The system cannot stand such a withdrawal of funds. They also must depend on assistance from Congress in supplying a second stimulus plan. That would probably be $400 to $800 billion. A lack of such funding would send the economy and the stock market into a tailspin. Even with such funding the economy cannot expect any growth to speak of and at best a sideways movement for perhaps a year.
We have been told that the FDIC not only is $8.2 billion in the hole, but they have secretly borrowed an additional $80 billion from the Treasury. We have also been told that the FDIC is lying about the banks in trouble. The number in eminent danger are not 552, but a massive 2,035. The cost of bailing these banks out would be $800 billion to $1 trillion. That means 2,500 could be closed in 2010. Now get this, the FDIC is going to be collapsed before the end of 2010, which means no more deposit insurance. This follows the 9/18/09 end of government guarantees on money market funds. Both will force deposits into US government bonds and agency bonds in an attempt to save the system.
This will strip small and medium-sized banks and force them into shutting down or being absorbed. This means you have to get your money out of banks, especially CDs. We repeat get your cash values out of life insurance policies and annuities. They are invested 80% in stocks and 20% in bonds. Keep only enough money in banks for three months of operating expenses, six months for businesses.
November 30, 2009
By Paul Joseph Watson
A fantastic article written by Christopher Brooker of the London Telegraph exposing the climate change fraud rocketed to the very top of a Google News search for “global warming,” only to disappear hours later.
“What is going on at Google? I only ask because last night when I typed “Global Warming” into Google News the top item was Christopher Booker’s superb analysis  of the Climategate scandal,” writes James Delingpole .
“It’s still the most-read article of the Telegraph’s entire online operation – 430 comments and counting – yet mysteriously when you try the same search now it doesn’t even feature. Instead, the top-featured item is a blogger pushing Al Gore’s AGW agenda. Perhaps there’s nothing sinister in this. Perhaps some Google-savvy reader can enlighten me.”
Another blogger noted how other versions of the article appeared, but the original had been “disappeared,” despite the fact that other London Telegraph articles showed up as the top ranked result when entering their headline.
“That is using the search string: “Climate change: this is the worst scientific scandal of our generation” – which is the full headline of the piece. It shows up where it has been quoted in full by other sites, but of the Booker column there is no sign,” writes Richard North .
In addition, searches for previous Christopher Brooker articles show up as top links – it’s only this particular article that has seemingly been targeted for censorship.
The same de-listing of the article is evident on other major search engine websites like Bing and Yahoo.
Search Engines Censoring ClimateGate? 121109banner2 
Despite the fact that Google has been caught gaming its search results in the past, this is more likely an “inside job” as it were.
It appears as if one of the editors at the Telegraph has gone into the backend of the Telegraph content management system and checked an option that prevents search engines from indexing a particular article.
“My guess is that this isn’t a Google issue. The problem probably lies closer to home – there looks to be an enemy in the camp, who has probably been using this , or something like it,” writes North, referring to a code that is inserted into a web page in order to block it from being ’spidered’. This is sometimes done to prevent site ripping and other hacks, but it also has the effect of barring search engines from being able to list the page in their results.
The fact that this has been applied to just this one article suggests that some higher-up at the Telegraph from the warmist camp was concerned about how the article had gone viral and wanted to contain its spread.
The fact that this attempt at sabotage has become a story within itself will probably only mean Brooker’s article will be read by more people, so the whole ruse has backfired.
November 30, 2009
By Ambrose Evans-Pritchard
Every single bank in Japan, the US, Germany, Spain, and Italy included in S&P’s list of 45 global lenders fails the 8pc safety level under the agency’s risk-adjusted capital (RAC) ratio. Most fall woefully short.
The most vulnerable are Mizuho Financial (2.0), Citigroup (2.1), UBS (2.2), Sumitomo Mitsui (3.5), Mitsubishi (4.9), Allied Irish (5.0), DZ Deutsche Zentral (5.3), Danske Bank (5.4), BBVA (5.4), Bank of Ireland (6.2), Bank of America (5.8), Deutsche Bank (6.1), Caja de Ahorros Barcelona (6.2), and UniCredit (6.3).
While some banks may look healthy under normal Tier 1 and leverage targets, critics claim these measures can be highly misleading since they fail to discriminate between high-risk and low-risk uses of leverage. The system failed to pick up the danger signals before the financial crisis. The supposedly moderate leverage of US banks in 2007 proved to be a spectacularly useless indicator.
S&P has shifted to a tougher code. It is less tolerant of hybrid capital – a liability rather than an asset, and no defence in a crunch – and insists that banks must quadruple capital put aside to cover trading desks. Private equity exposure will be treated more harshly.
The Bank for International Settlements unveiled its own version in September. The regulatory framework worldwide is clearly shifting in this direction, a move that will hit some banks harder than others. “We expect banks to continue strengthening capital ratios over the next 18 months to meet more stringent requirements. Failure to achieve this could put renewed pressure on ratings,” said Bernard de Longevialle, S&P’s credit strategist.
Tougher rules at this juncture may prove “pro-cyclical”, if banks respond by cutting loans. This may perpetuate the credit crunch for smaller borrowers unable to tap the bond markets. “There is a risk that the increase in regulatory capital requirements could weigh on banks’ ability to finance recovery,” said Mr de Longevialle.
The “safest” global bank is HSBC (9.2), followed by Dexia (9.0), ING (8.9) and Nordea (8.8). UK banks fare relatively well: Standard Chartered (8.1) is in the top quintile; Barclays (6.9) is in the middle. The study left out RBS and Lloyds because their status is unclear. Chinese banks – the world’s largest – were excluded.
Many banks on the sick list are already cleaning up their books, mostly by disposing of assets or converting hybrids into common stock. Citigroup exchanged $64bn (£38.5bn) of hybrid equity in the third quarter. UBS has cut reliance on hybrids, still 80pc of its capital earlier this year.
Japanese banks score worst because they rely on hybrids and are major players on the stock exchange, buying equities at 12 times leverage. Equity portfolios make up more than 50pc of their capital. This could prove troublesome given Tokyo’s bourse has fallen this year, missing out on the global rally.
German banks do poorly because they have large holdings of asset-backed securities (ABS), often toxic. US banks look healthy in terms of leverage, but look less pretty when this is adjusted for risk.
S&P said past focus on leverage alone had been a recipe for trouble. It encouraged banks to opt for dodgy products – treated as if equal to top-notch sovereign debt – and could be circumvented “off-books” in any case. Rules created the illusion of safety.
November 30, 2009
By Bob Chapman
Investors buy gold when there is inflation and when there is a flight to quality. They buy gold when they no longer trust currencies, due to government or central bank profligacy. Due to those and other reasons gold has broken out to new highs. It could well be that gold may never see $1,000 again. Long ago the world’s central banks set the course for a planned collapse of the world economy to implement world government and there is now no turning back. We have proof stretching back to 1965 that intervention by the Treasury and the Fed was taking place in the gold market. The illegal sale of gold on 10/19/87 was a good example of that. Then came the FOMC memos of the 1980s and 1990s to kill the perception that gold be allowed to reflect a policy of a weak dollar unbacked by gold. It is all there and probably more proof which our government and the Fed hides from us. We have to laugh at the smug who say why would the Treasury bother to rig the gold price? The point is they have and they are still doing it.
The perception now is that the massive stimulus put into international markets, especially US markets, will be withdrawn as interest rates are allowed to float upward. This stimulus was responsible for the stock market climbing from Dow 6600 to 10,500, a 60% leap built on monetization. If the punch bowl is removed the market will return to test 6600. In addition, the deflationary undertow kept at bay by the stimulus, will overcome monetary policy and the nation and the world will slip into monetary, deflationary depression.
The Fed is now forced to allow gold to trade higher and the dollar to fall lower. What else would one expect under current monetary circumstances? This policy will allow both gold and the dollar to play out to their full extent. The Fed’s job has been very difficult considering a fiscal budget deficit of $1.5 trillion not counting off budget items that take it over $2 trillion – a condition we are told that will persist for the next ten years. The solution has been the creation of ever more money and credit. There has been no cooperation. Nothing has worked together. All the problems have gone spinning off into a number of directions. There is no control on fiscal or monetary policy. What the players refuse to understand is that until the system is purged the situation is only going to get worse. There is no recovery. It is only an interlude in an ongoing depression.
The result will be gold at $2,500 by the end of 2010, and perhaps much sooner. The buyers know what we know. Real inflation since 1980 dictates $6,700 to $7,200 gold. Even official inflation demands a $2,400 price. In both instances how much inflation will 2010 bring? We are projecting 14% real inflation and government and the Fed keep telling us inflation is 1.2%. Our figures show 6-1/8%. In addition the fundamentals show us that gold production has been in shortfall to usage by 150 or more tons for years and that situation will worsen over the next ten years. Yes, we have hit peak gold. Interest rates rises won’t come for at least a year, if ever, and 5% growth in aggregates is in the realm of wishful thinking. Less gold is currently produced annually than in 1980 and there are trillions more dollars sloshing about the world financial system, a good part of it for speculative purposes. Without changes in monetary and fiscal policies, gold and silver prices will just keep rising. The further our government, via Goldman Sacks, JPMorgan Chase, HSBC and Citigroup, short gold and silver and the shares, the greater price appreciation will be in the future as they ultimately will have to cover their shorts. We are at the confluence of big things happening. The fiscal debt overhand is so onerous that a ¾% rise in interest rates would mean the Fed would have to monetize another $150 billion and a 5% increase in interest rates would increase debt service interest by $600 billion additional dollars. Yes, gold could reach $3,000 in 2010 and 2011 could bring another doubling as a result of the Fed and government just continuing what they are doing. Will inflation reach 25% or 30% in 2011? We don’t know, but as we reflect on what the Fed has been doing we say that possibility certainly exists. Could that mean $11,000 gold? Perhaps it does, we won’t know until we get there.
Even if inflation abated in 2011 or 2012 and a deflationary depression took command, gold would still be the go to investment. That is because for 6,000 years it has been the only currency that has owed no one anything. Would you really be ready to trade it for a fiat currency? We don’t think so. All bond markets as well as stock markets would have collapsed with the exception of gold and silver shares. Just look at the 1930s and see the gains Homestake had, if you don’t think gold stocks can make fortunes during a depression. Gold and silver are the investments for all seasons as long as you have patience. The banking system may collapse. What better to use than gold and silver coins for barter. This past year we have seen lending by banks fall 16.2% y-o-y or by $600 billion. Just double that figure and you are in depression. Can you imagine what it will be like with little or no lending? Unemployment is 22.2%. Under such conditions the unemployed could be 35% or more. What do we do, let the Illuminati create another world war to cover up their machinations? The dollar is already falling and probably will eventually collapse. Could it be 1-1/2 to 2-1/2 years from now that there will be an official 2/3’s devaluation? The exchange of three old dollars for one new dollar and a 2/3’s default on all debt by all nations with one another and the revaluation and devaluation of all currencies followed by a new international trading unit made up of the top G-20 currencies weighted in an index. That is certainly plausible as the dollar ceases to be the international reserve currency.
These events could push residential and commercial values down 75% or more from their highs. All investments except gold and silver could fall 60% to 95% as they did during the 1930s. The Fed won’t be able to cut interest rates, which will already be at zero. Demand for capital will force real rates higher and bonds lower. All issuers of consumer debt will most likely go broke, as 50% of debtors won’t be able to service their debt.
Real nasty times are just around the corner and nothing can be done to prevent them. The system must be purged. More major layoffs are on the way, real wages will fall and taxes will rise. The Dow will settle somewhere between 1,500 and 4,200. We won’t know where until we get a lot closer. Companies have maintained the bottom line by firing people, offshoring and outsourcing and using illegal aliens. That method of cutting costs is approaching a threshold of diminishing returns. The next big wave of layoffs will be municipal in towns, cities, counties and states that no longer have the reserve to pay employees. Some states, such as Florida has no funds to pay for unemployment benefits and were it not for the stimulus plan they would have stopped issuing checks a year ago. At this rate in many states municipalities will cease to function and schools, fire and police will be disbanded. That is where this is all headed. Americans have to be told the truth about what is really going on and who and what caused it and how we can fix it.
November 30, 2009
By Bruce Japsen
Deerfield-based Baxter International Inc. says it is looking into building a cell-based vaccine manufacturing plant in the U.S. to produce seasonal and pandemic flu vaccines.
The company won’t say when a plant could be built because the timing would depend on the outcome of a government-funded clinical trial of its seasonal product, which is in its final stages. A timetable will be clearer when the company can determine the success of its seasonal and pandemic flu vaccine development program.
Baxter is the latest drugmaker to express interest in the potentially lucrative business of producing vaccines in the U.S. Although companies historically have complained of little profit from flu vaccines, increased government subsidies are making the business more attractive. And Baxter’s cell-based technology would speed up the production time.
Swiss drug giant Novartis AG earlier this week began design and construction on a $1 billion cell-based manufacturing plant in North Carolina, which is backed by more than $400 million in federal funds. But the plant won’t be running at full-scale commercial production until 2013, the company said, though it could produce vaccines in an emergency as soon as 2011.
Drugmakers are building or considering vaccine plants as capacity issues stymie governments worldwide, causing shortages and rationing of vaccines for seasonal and pandemic viruses.
But critics say more should be done.
“America needs to produce vaccines and therapeutics faster and less expensively than we have been because we might not have six months of advance warning for the next pandemic,” said retired Col. Randy Larsen, executive director of the Commission on the Prevention of Weapons of Mass Destruction Proliferation and Terrorism, a bipartisan group created by Congress that is advocating more money for vaccine development. “We need more capacity.”
Larsen said the commission is pushing the U.S. to spend $3 billion a year — 10 times the annual spending currently budgeted — to enhance “U.S. vaccine preparedness.” The commission also is trying to mobilize the public behind its effort through its Web site, FasterVaccines.org.
“Whether the threat is from naturally occurring disease or bioterrorism, the United States needs to be able to produce vaccines and other medicines faster and less expensively,” said former U.S. Sen. Bob Graham, chairman of the commission. “Creating the infrastructure for rapid development of large quantities of safe vaccines and medicine is a win-win for public health and national security.”
Baxter and Novartis are among those companies that have benefited from federal dollars and are considered furthest along using cell-based technology, which allows manufacturers to cut production times in half compared with the 1940s-era processing by hand of millions of chicken eggs. The cell-based method can generate yields in about 13 weeks, compared with 24 weeks in egg-based manufacturing — the U.S.-approved method of making pandemic and seasonal vaccines.
Both are making vaccines to prevent the spread of the H1N1 virus in Europe, where the cell-based method is approved. Baxter executives said their plant in the Czech Republic is running at capacity, filling contracts for vaccine with a half-dozen countries overseas.
In the U.S., more is expected to be known by next flu season with Baxter conducting final stage clinical trials for its seasonal flu vaccine this year. Companies that won U.S. contracts to make the H1N1 vaccine were those that already produce seasonal vaccines for Americans with the older, egg-based method.
“Although Baxter is not supplying H1N1 vaccine to the U.S., the company has been keeping the Department of Health and Human Services fully briefed on its progress with its Celvapan H1N1 development program,” Baxter said in a statement to the Tribune. “From Baxter’s perspective, the Department of Health and Human Services and the U.S. government have done an excellent job of exploring ways and implementing partnerships to advance and adopt new vaccine technology in the U.S. The funding, and development challenges are many and simply take time.”
For its part, the FDA said it can’t comment on Baxter’s trial or any expected application for approval.
In general, however, the agency said a standard review of a company’s application for a drug or vaccine can take 10 months before a product is licensed. Expedited reviews are common and can be completed in six months, but the agency would not speculate on whether Baxter or other vaccine-makers would be granted such priority.
“FDA does not approve or license a facility separately from the product itself,” an FDA spokeswoman said. “The facility, manufacturing protocols, data and final product are all part of the approval or licensing package.”
November 30, 2009
By Dr. Mercola
One night inside a George Washington University fraternity, a sky-diving, weight-lifting, energy-drink-swilling group of brothers gathered around a pool table, boasting about how no matter what their college, government and parents might say, they don’t need any swine flu vaccine, thanks very much.
They view the virus’s threat as a media-concocted sensation. They fend off their parents’ — and even their girlfriends’ parents’ — worries, much as they do concerns about any other risky behavior, such as parachuting out of an airplane for an upcoming frat event.
Nearly seven out of 10 people in the 18-to-29 age group said they did not plan to heed warnings to get vaccinated, a Washington Post-ABC News poll found. Puzzled experts at the Centers for Disease Control and Prevention said they are so concerned about young people’s lack of concern about swine flu that they are conducting surveys to tease out the basis for the blasé attitudes.
According to an ABC News-Washington Post poll on October 22, nearly 7 out of 10 people in the 18-29 age bracket said they will not get the H1N1 vaccine. Ditto for 62 percent of those aged 30-64, and 53 percent of seniors, aged 65 and over.
Are Parents Letting Unfounded Fears Get the Better of Them?
Unfortunately, according to this poll, 56 percent of parents now plan to have their children vaccinated, including 4 percent who have already done so. Even worse, 13 percent of parents who have doubts about the vaccine’s safety are still planning on having their kids vaccinated!
I find it curious that so many adults are still willing to submit their children to this vaccine, while 62 percent of these same adults are refusing it for themselves…
Another curious finding from this poll is that since August, the percentage of people worried about coming down with the swine flu has risen quite dramatically, from 39 percent in August, to 52 percent as of October 22.
Again, I can only hope that those who “worry” about the swine flu will get the information I’ve been posting during the past several months, especially in the past few weeks, which clearly shows there’s really nothing to fear from the swine flu virus.
So please do continue sharing this information with your friends and family, especially those with children, or who are pregnant.
There’s Nothing to Fear But Fear Itself!
This year, flu deaths are being trumpeted across the world, and yet people are also dying and suffering life-altering disabilities shortly after receiving the flu vaccine, whether it be the seasonal- or the H1N1 vaccine.
Adverse reactions such as paralysis or even death after vaccination are especially tragic when you consider the fact that the real danger of the swine flu is so minimal.
People are still not realizing that the mortality statistics for H1N1 are being deceptively reported and are NOT accurate – the vast majority of those who died did most likely not even have the H1N1 virus, but rather succumbed from other viral or bacterial causes and complications.
I urge you to read my previous article, CBS Reveals that Swine Flu Cases Seriously Overestimated, if you have not already done so, to get a much clearer picture of this overhyped threat.
For example, according to the CBS News investigation, when you come down with chills, fever, cough, runny nose, malaise and all those other “flu-like” symptoms, the illness is likely caused by influenza at most 17 percent of the time, and as little as 3 percent!
The other 83 to 97 percent of the time it’s caused by other viruses or bacteria.
Based on this fact, and the fact that the CDC changed the way they count “H1N1 cases” as of the end of August to now include any and all “flu-like symptoms,” it’s quite possible that current mortality statistics are exaggerated by as much as 80-90 percent, or more!
In addition, statistics still show that this year is one of the mildest flu seasons in years, with the fewest amounts of deaths!
The current worry about contracting the swine flu is truly based on nothing but media-induced fear. The threat itself is simply NOT REAL.
Information is Power
You can help make a BIG difference by helping inform your friends and relatives, and posting this information on your Facebook pages and other social networking sites.
In addition, you can help protect your, and everyone else’s, right to make informed, voluntary vaccination choices by supporting the National Vaccine Information Center.
I have made this non-profit organization — America’s Vaccine Safety
Watchdog — one of my favorite charities and I urge you to become a donor member and help NVIC protect your informed consent rights and your children’s health.
November 30, 2009
By Angela Kamper
“It could have happened in a lab where somebody became affected and then travelled with it,” virologist Dr Adrian Gibbs said yesterday.
Conjuring up a vision of Frankenstein’s fictional monster fleeing the laboratory, he added: “Things do get out of labs and this has to be explored. There needs to be more research done in this area.
“At the moment there is no way of distinguishing where swine flu has come from.”
The research, published in the Virology Journal on Tuesday, was compiled by two former researchers at the Australian National University – Dr Gibbs and programmer John S. Armstrong.
Dr Jean Downie, once the head of HIV research at Westmead Hospital, was also involved.
The article claimed the swine-origin influenza A (H1N1) virus that appeared in Mexico in April has at least three parent genes which originated in the US, Europe and Asia.
“The three parents of the virus may have been assembled in one place by natural means, such as by migrating birds, however the consistent link with pig viruses suggests that human activity was involved,” the research found.
Within two days of them publishing their findings there were more than 16,000 downloads of the article.
“What we wanted to do was instigate debate about this again because we still don’t know the source of this virus,” Dr Gibbs said.
The research suggested more tests be done on laboratories “which share and propagate a range of swine influenza viruses”.
It said that if the virus was generated by laboratory activity it would explain why it had “escaped surveillance for over a decade”.
Dr Gibbs said it was not the first time lab errors had been made, with evidence foot and mouth disease in England had been born out of a lab mistake and circumstantial evidence that Spanish influenza in 1918 and Asian influenza in 1957 reappeared decades later because of mistakes.
“Measures to restore confidence include establishing an international framework co-ordinating surveillance, research and commercial work with this virus and a registry of all influenza isolates held for research and vaccine production,” the report concluded.
November 30, 2009
By Stefanie McIntyre
China must be alert to any mutation or changes in the behavior of the H1N1 swine flu virus because the far deadlier H5N1 bird flu virus is endemic in the country, a leading Chinese disease expert said.
Zhong Nanshan, director of the Guangzhou Institute of Respiratory Diseases in China’s southern Guangdong province, said the presence of both viruses in China meant they could mix and become a monstrous hybrid — a bug packed with strong killing power that can transmit efficiently among people.
“China, as you know, is different from other countries. Inside China, H5N1 has been existing for some time, so if there is really a reassortment between H1N1 and H5N1, it will be a disaster,” Zhong said in an interview with Reuters Television.
“This is something we need to monitor, the change, the mutation of the virus. This is why reporting of the death rate must be really transparent.”
The World Health Organization warned on Tuesday that H5N1 had erupted in poultry in Egypt, Indonesia, Thailand and Vietnam, posing once again a threat to humans.
“First, it places those in direct contact with birds — usually rural folk and farm workers — at risk of catching the often-fatal disease. Second, the virus could undergo a process of “reassortment” with another influenza virus and produce a completely new strain,” it said.
“The most obvious risk is of H5N1 combining with the pandemic … (H1N1) virus, producing a flu virus that is as deadly as the former and as contagious as the latter.”
Zhong told the Chinese media last week that China may have had more H1N1 flu deaths than it has reported, with some local governments possibly concealing suspect cases.
The doctor is known for his candor and work in fighting Severe Acute Respiratory Syndrome in 2003, when nationwide panic and international alarm erupted after it emerged that officials hid or underplayed the spreading epidemic.
Cover-ups by local governments in 2003 during the SARS epidemic led to the sackings of several officials. More than 300 people died in that outbreak.
China, the world’s most populous country, has reported around 70,000 cases of H1N1 and 53 death from the virus.
While some regions simply lack the technology to test for H1N1, other areas have been treating deaths as cases of ordinary pneumonia without a question, Zhong said.
“Some local healthcare authorities are reluctant, unwilling to test patients with severe pneumonia because there’s some latent rule which says the more H1N1 deaths, the less effective the control and prevention work in your area,” Zhong said.
Zhong said China’s health minister Chen Zhu rang him up last week and agreed with his views. A notice then appeared on the ministry’s website threatening severe punishment for officials caught concealing deaths from H1N1 swine flu.
WHO reported more than 526,060 laboratory confirmed cases of H1N1 worldwide on November 15, with at least 6,770 deaths. However, it has stressed for months now that the figures were only the tip of the iceberg.
It urged countries to place more resources on mitigating the disease rather then on costly prevention measures or testing everyone. All WHO and the U.S. CDC will say is that “millions” have been infected.
November 30, 2009
By Novye Izvestija
The Swine Flu Pandemic which Novye Izvestija has written about many times, may be the most ambitious scam and corruption of our time. In any case, the enormous commercial aspect of the “swine flu scare” is already evident.
The same conclusion was reached by Danish journalists who expertly examined the links between the World Health Organization (WHO) and the world’s leading pharmaceutical companies, who gained wealth by selling drugs to counter the disease. It turns out, for example, that many scientists who sit on various committees of WHO, carefully concealed the fact that they receive money from the giant pharmaceutical companies of the world.
According to the international investment bank JP Morgan, the pharmaceutical industry will make more than 7 Billion Euros this year on the sale of A/H1N1 vaccines. Leading western countries have ordered enough doses to vaccinate either their entire population (such as Australia) or one third (Germany and several other EU member States). Factories making the vaccines and pills are working around the clock, in four shift rotations, with a backlog of orders …they are not experiencing the global economic crisis as others might.
For the first time in many years flu pandemic ‘panic’ has affected the EU. The vaccine has been produced without a sufficient number of clinical and laboratory tests.
Is such a panic justified? a growing number of specialists are examining the issue by comparing the mortality statistics from the swine flu virus and it’s ‘conventional’ varieties, each Autumn they begin their march across the planet. So far, according to WHO, six thousand people have fallen victim to A/H1N1, while the average annual death rate during epidemics of ‘traditional’ varieties of flu reaches half a million.
The main cause of the hysterical response to the swine flu epidemic, according to reporters from the Danish newspaper ‘Information’, is not because it is so dangerous, but because of a strong public relations campaign by experts from WHO. Some of them [WHO experts] are literally in the service of the vaccine manufacturers.
“It is disturbing that many of the scientists who sit on various committees of WHO, are presented as ‘independent experts’, but they carefully conceal the fact that they receive money from pharmaceutical companies”, Professor of epidemiology, Tom Jefferson, who works at the Cochrane Center in Rome, told reporters.
WHO announced the swine flu pandemic under pressure from a panel of advisers, headed by a Dutch doctor, Albert Ostenhaus, nicknamed ‘Dr. Flu’ (from the name ‘Tamiflu’) because he was active in promoting mass vaccination of the population through WHO and the Western media. Now the government of the Netherlands is conducting an emergency investigation into the activities of ‘Doctor Flu’, as it became known that he receives a salary from several vaccine manufacturing companies. Many other WHO advisers sit ‘on two chairs’ (conflict of interest) like Ostenhaus, and while dealing with the swine flu pandemic on behalf of WHO, they do not like to advertise that they are paid advisers to pharmaceutical giants Roche, RW Johnson, SmithKline and Beecham Glaxo Wellcome, who have received the lion’s share of orders for manufacturing of vaccines. The result of pressure from these experts was the resolution of WHO on 7th July this year, which called for an unprecedented campaign of mass vaccination.
“The WHO is biased in their recommendations – says Professor Tom Jefferson. – Normal hygiene measures provide much greater effect than these little-studied vaccines, and at the same time WHO refers to the use of masks and hand-washing as a means to combat swine flu only twice in their documents. Vaccines and other medications are referred to 42 times!” Dr. Jefferson and several of his colleagues believe that paid advisers of the pharmaceutical companies should be removed from their positions and not allowed to give recommendations to the WHO, but the organization itself is in no hurry to carry out such a reform. WHO spokesperson, Gregory Hertl, commenting on the article in ‘Information’ (Danish newspaper) said it is impossible to deny the services of the world’s leading experts on the sole ground that they have a financial interest in the promotion of a strategy to combat various diseases.
It should be noted that this is not the first year that ’scope for corruption’ in pharmacology has been the focus of the Western media. The New England Journal of Medicine published ‘The Whistleblower’ several years ago. In a series of articles the Whistleblower showed the inside life of the ‘medical mafia’. According to them, only 11-14% of pharmaceutical companies budgets are spent on research, but 36% of funds are spent on PR. Much of the money ends up in the pockets of doctors, scientists, and the accounts of various organizations working in health care.